{"entity":{"type":"insider","cik":"0001289739","url":"/insider/0001289739","json_url":"/insider/0001289739.json","name":"Slater Eve Elizabeth","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":4,"first":"2006-03-27","last":"2007-05-30","span_basis":"filed_date"},"name_variants":[{"name":"Slater Eve Elizabeth","source":"filing","n_filings":4,"first_seen":"2006-03-27","last_seen":"2007-05-30"}],"transactions":[{"id":7334388,"accession":"0000875320-07-000056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-07-000056","line_url":"/filing/0000875320-07-000056#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001289739","owner_name":"Slater Eve Elizabeth","owner_display_name":"Slater Eve Elizabeth","owner_url":"/insider/0001289739","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.42,"price_display":"30.42","price_state":"stated","total_value":304200.0,"total_display":"304,200.00","total_whole":"304,200","shares_owned_after":1105.0,"shares_owned_after_display":"1,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-29","filed_date":"2007-05-30","scope":"insider"},{"id":7396543,"accession":"0001072613-07-000543","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001072613-07-000543","line_url":"/filing/0001072613-07-000543","is_derivative":false,"issuer_cik":"0001050180","issuer_name":"PHASE FORWARD INC","issuer_ticker":"PFWD","issuer_name_source":null,"issuer_url":"/issuer/0001050180","owner_cik":"0001289739","owner_name":"Slater Eve Elizabeth","owner_display_name":"Slater Eve Elizabeth","owner_url":"/insider/0001289739","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1700.0,"shares_display":"1,700","price_per_share":13.486547058823529,"price_display":"13.49","price_state":"stated","total_value":22927.13,"total_display":"22,927.13","total_whole":"22,927","shares_owned_after":1700.0,"shares_owned_after_display":"1,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-26","filed_date":"2007-02-28","scope":"insider","n_lines":4},{"id":5218345,"accession":"0000875320-06-000052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-06-000052","line_url":"/filing/0000875320-06-000052#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001289739","owner_name":"Slater Eve Elizabeth","owner_display_name":"Slater Eve Elizabeth","owner_url":"/insider/0001289739","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":455.0,"shares_display":"455","price_per_share":31.98,"price_display":"31.98","price_state":"stated","total_value":14550.9,"total_display":"14,550.90","total_whole":"14,551","shares_owned_after":1105.0,"shares_owned_after_display":"1,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-17","filed_date":"2006-06-02","scope":"insider"},{"id":3717617,"accession":"0000875320-06-000032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-06-000032","line_url":"/filing/0000875320-06-000032#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001289739","owner_name":"Slater Eve Elizabeth","owner_display_name":"Slater Eve Elizabeth","owner_url":"/insider/0001289739","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":650.0,"shares_display":"650","price_per_share":36.0,"price_display":"36.00","price_state":"stated","total_value":23400.0,"total_display":"23,400.00","total_whole":"23,400","shares_owned_after":650.0,"shares_owned_after_display":"650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-03-23","filed_date":"2006-03-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Director","n_filings":3,"first_seen":"2006-03-27","last_seen":"2007-05-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001050180","name":"PHASE FORWARD INC","url":"/issuer/0001050180","role":"Director","n_filings":1,"first_seen":"2007-02-28","last_seen":"2007-02-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001289739","retrieved_at":"2026-08-26T16:19:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}